A registered study demonstrated that high-dose plasmid-mediated VEGF gene expression in ischemic myocardial tissue can enhance the prognosis of ischemic heart disease.577 Collectively, these findings underscore the remarkable therapeutic potential of VEGF in cardiovascular disorders, particularly in the context of ischemic heart disease. Here, VEGFA is linked to coronary artery disorder.